¿¨¿¨Íå88

¹ÉƱÐÅÏ¢£¨01093.HK)

EN ·±Ìå / ¼òÌå /

¹«Ë¾ÐÂÎÅ

COMPANY NEWS

  • °²¸´Àû¿Ë?ÖÎÁÆÃ«Ã¹¾ú²¡ÁÆÐ§ÓëÇå¾²ÐÔµÄÒ»ÏîÕæÊµÌìÏÂÑо¿Ð§¹û

    2026-02-25

    ½üÆÚ£¬ £¬£¬£¬£¬£¬£¬¸´µ©´óѧÁ¥ÊôÎ÷ÔÀÒ½ÔºÖìÀûƽ½ÌÊÚÔÚ¹ú¼ÊÆÚ¿¯¡¶BMC Infectious Diseases¡·½ÒÏþÁËÌâΪ¡°Efficacy and safety of amphotericin B colloidal dispersion in the treatment of mucormycosis: a real-world observation¡±µÄÕæÊµÌìÏÂÑо¿£¬ £¬£¬£¬£¬£¬£¬¸ÃÑо¿ÆÀ¹ÀÁËÁ½ÐÔÃ¹ËØBµ¨¹Ì´¼ÁòËáõ¥¸´ºÏÎABCD£¬ £¬£¬£¬£¬£¬£¬ÉÌÆ·Ãû£º°²¸´Àû¿Ë?£©ÖÎÁÆÃ«Ã¹¾ú²¡µÄÁÆÐ§ÓëÇå¾²ÐÔ£¬ £¬£¬£¬£¬£¬£¬ÎªÁÙ´²ÌṩÁËеÄÓÐÁ¦Ö¤¾Ý¡£¡£¡£¡£¡£

  • ʯҩ¼¯ÍÅÒ»ÏîÁ¢ÒìÒ©Ñо¿Ð§¹ûÈëÑ¡2026ÄêÅ·Ö޷ΰ©´ó»á(ELCC)

    2026-02-11

    3ÔÂ25ÈÕÖÁ28ÈÕ£¬ £¬£¬£¬£¬£¬£¬Å·Ö޷ΰ©´ó»á£¨ELCC£©½«ÔÚµ¤Âó¸ç±¾¹þ¸ù¾ÙÐÐÕÙ¿ª¡£¡£¡£¡£¡£Ê¯Ò©¼¯ÍÅÔÚ±¾½ìÅ·Ö޷ΰ©´ó»áÉϽ«Õ¹Ê¾Ò»ÏîÁ¢ÒìÒ©µÄ×îÐÂÁÙ´²Ñо¿Ï£Íû¡£¡£¡£¡£¡£

  • ºÓ±±Ê¡Ê¯Ò©ÆÕ¶÷´ÈÉÆ»ù½ð»áÈÙ»ñ¡°ÌìÏÂÏȽøÉç»á×éÖ¯¡±³Æºô

    2026-02-05

    2ÔÂ2ÈÕÉÏÎ磬 £¬£¬£¬£¬£¬£¬¹ú¼ÒÃñÕþ²¿ÕÙ¿ªµÚÎå´Î¡°ÌìÏÂÏȽøÉç»á×éÖ¯¡±±íÑï´ó»á£¬ £¬£¬£¬£¬£¬£¬ºÓ±±Ê¡Ê¯Ò©ÆÕ¶÷´ÈÉÆ»ù½ð»á×÷Ϊ»ñ½±µ¥Î»²Î»á²¢Áì½±¡£¡£¡£¡£¡£

  • ʯҩ¼¯ÍÅÈÙ»ñ¡°×îÁµÈ˲ŹÍÖ÷¡±³Æºô

    2026-02-02

    ¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬BOSSֱƸ¡°ECHO AWARDS 2026 Ò»ÆðÉú³¤¡±°ä½±Ê¢µäÔÚ±±¾©Ê¢´óÆôÄ»£¬ £¬£¬£¬£¬£¬£¬Ê¯Ò©¼¯ÍÅÒÀ¸½ÔÚÈ˲ÅÎüÒý¡¢×÷Óý¡¢Áô´æÓ븳ÄÜÉϵÄ׿ԽÌåÏÖ£¬ £¬£¬£¬£¬£¬£¬´ÓÖÚ¶àÆóÒµÖÐÍÑÓ±¶ø³ö£¬ £¬£¬£¬£¬£¬£¬Õ¶»ñÄê¶È¡°×îÁµÈ˲ŹÍÖ÷¡±³Æºô£¬ £¬£¬£¬£¬£¬£¬ÒÔÓ²ºËʵÁ¦ÌÜдÐÐÒµ¹ÍÖ÷Æ·ÅÆÐ±ê¸Ë£¡

  • 2026-01-27

    ʯҩ¼¯ÍÅÁ¢ÒìÒ©Ñо¿Ð§¹ûÈÙµÇÖ×Áöѧ¶¥¿¯¡¶Annals of Oncology¡·

    ¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬ÓÉʯҩ¼¯ÍÅÓë½­ËÕ¿µÄþ½ÜÈðÉúÎïÖÆÒ©ÓÐÏÞ¹«Ë¾ÏàÖú¿ª·¢µÄ°²ÄáÍ×µ¥¿¹(KN026)Õë¶ÔHER2ÑôÐÔθ°©/θʳ¹ÜÍŽᲿÏÙ°©»¼ÕßµÄIIIÆÚÁÙ´²Ñо¿Ð§¹ûÀֳɽÒÏþÓÚÖ×ÁöѧÁìÓò¶¥¼¶ÆÚ¿¯¡¶Ö×ÁöѧÄê¼ø¡·(Annals of Oncology£¬ £¬£¬£¬£¬£¬£¬IF£º65.4)£¬ £¬£¬£¬£¬£¬£¬ÎÊÌâΪAnbenitamab in previously treated HER2-positive gastric cancer (KC-WISE): pre-specified interim analysis of a randomized, phase III clinical trial¡£¡£¡£¡£¡£

  • 2026-01-19

    ʵÁ¦µÇ°ñ£¡Ê¯Ò©¼¯ÍÅÃ÷¸´ÀÖÈÙ»ñ¡°¹ãÖÝÊÐÁ¢Òìҩе¡±³Æºô

    ʯҩ¼¯ÍÅÃ÷¸´ÀÖÒ©Òµ£¨¹ãÖÝ£©ÓÐÏÞ¹«Ë¾½¹µã²úÆ·Ã÷¸´ÀÖ?ÍÑÓ±¶ø³ö£¬ £¬£¬£¬£¬£¬£¬ÀÖ³ÉÈëÑ¡¡¶¹ãÖÝÊÐÁ¢Òìҩе²úƷĿ¼£¨µÚ¶þÅú£©¡·£¬ £¬£¬£¬£¬£¬£¬²¢ÈÙ»ñ¡°¹ãÖÝÊÐÁ¢Òìҩе¡±³Æºô£¬ £¬£¬£¬£¬£¬£¬³ÉΪÉúÎïÒ½Ò©Á¢ÒìÁìÓòµÄ±ê¸Ë´ú±í¡£¡£¡£¡£¡£

  • 2026-01-16

    Ê¯Ò©Òøºþ¹ùÁ¼ÀÍÄ£Á¢ÒìÊÂÇéÊÒÈÙ»ñÔ˶¼»á¡°Êм¶ÀÍÄ£Á¢ÒìÊÂÇéÊÒ¡±³Æºô

    ¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬É½Î÷Ê¡Ô˶¼»á×ܹ¤»áÐû²¼¡¶¹ØÓÚÖØµãÖ§³ÖµÚ°ËÅúÀÍÄ££¨¹¤½³£©Á¢ÒìÊÂÇéÊÒ Ö°¹¤Á¢ÒìÊÂÇéÊÒ ¹Å°åÊÖ¹¤ÒÕ ¾Þ½³Á¢ÒìÊÂÇéÊÒµÄ֪ͨ¡·£¬ £¬£¬£¬£¬£¬£¬Ê¯Ò©¼¯ÍÅÒøºþÖÆÒ©ÓÐÏÞ¹«Ë¾£¨Ï³ƣºÊ¯Ò©Òøºþ£©¹ùÁ¼ÀÍÄ£Á¢ÒìÊÂÇéÊÒÔÚÆÀÑ¡ÖÐÍÑÓ±¶ø³ö£¬ £¬£¬£¬£¬£¬£¬ÀֳɻñÆÀ¡°Êм¶Ö°¹¤Á¢ÒìÊÂÇéÊÒ¡±³Æºô¡£¡£¡£¡£¡£

  • 2026-01-16

    ʯҩ¼¯ÍÅËļÒ×Ó¹«Ë¾Í¬²½õÒÉíºÓ±±Ê¡ÌØÉ«¹¤Òµ¼¯Èº¡°ÁìÅÜÕß¡±ÐÐÁÐ

    ʯҩ¼¯ÍÅÆìÏÂËļÒ×Ó¹«Ë¾¡ª¡ªÊ¯Ò©¼¯ÍÅÖÐŵҩҵ£¨Ê¯¼Òׯ£©ÓÐÏÞ¹«Ë¾£¨ÖÐŵҩҵ£©¡¢Ê¯Ò©¼¯ÍžÞʯÉúÎïÖÆÒ©ÓÐÏÞ¹«Ë¾£¨¾ÞÊ¯ÖÆÒ©£©¡¢Ê¯Ò©¼¯ÍÅάÉúÒ©Òµ£¨Ê¯¼Òׯ£©ÓÐÏÞ¹«Ë¾£¨Î¬ÉúÒ©Òµ£©¡¢Ê¯Ò©¼¯ÍŶ÷±ØÆÕÒ©ÒµÓÐÏÞ¹«Ë¾£¨¶÷±ØÆÕÒ©Òµ£©Í¬²½ÀÖ³ÉõÒÉí°ñµ¥£¬ £¬£¬£¬£¬£¬£¬³ÉΪºÓ±±ÉúÎïÒ½Ò©¹¤Òµ¼¯Èº¸ßÖÊÁ¿Éú³¤µÄ½¹µã±ê¸ËʵÁ¦¡£¡£¡£¡£¡£

  • 2026-01-14

    ¼ÓÈëÊ餻á´ú±í´ó»áºó£¬ £¬£¬£¬£¬£¬£¬ËýÄÑÑÚ¼¤¶¯Ð´ÏÂÕâÆª¸ÐÑÔ

    ÌØÊâÊÇÌýµ½»áÉϱ¨¸æ£¬ £¬£¬£¬£¬£¬£¬×÷Ϊʯ¼ÒׯÊеÄÒ»Ãû¹«Ãñ£¬ £¬£¬£¬£¬£¬£¬×÷Ϊʯҩ¼¯ÍŵÄÒ»ÃûÖ°¹¤£¬ £¬£¬£¬£¬£¬£¬ÎÒÐÄÌïµÄ×ÔºÀ¸ÐÓëʹÃü¸ÐÓÍÈ»¶øÉú£¬ £¬£¬£¬£¬£¬£¬ÍŽṫ˾Á¢ÒìÊÂÇéÊÒµÄʵ¼ùÓë»ñ½±ÂÄÀú£¬ £¬£¬£¬£¬£¬£¬¸üÈÃÎÒ¶Ô ¡°¹¤»á´į̂¡¢Ö°¹¤Á¢Òì¡¢ÆóÒµÔöЧ¡¢¶¼»á¸³ÄÜ¡± µÄÉú³¤Â·¾¶ÓÐÁËÉî¿Ì¸ÐÎò¡£¡£¡£¡£¡£

  • 2026-01-09

    ʯҩ¼¯ÍÅ¡°Àî´ºÀ×Á¢ÒìÊÂÇéÊÒ¡±ÈëÑ¡ÌìÏÂ×ܹ¤»áÖØµãÖ§³ÖÃûµ¥

    ¿ËÈÕ£¬ £¬£¬£¬£¬£¬£¬ÖлªÌìÏÂ×ܹ¤»á°ì¹«ÌüÕýʽÐû²¼ÁË¡¶2025ÄêÌìÏÂ×ܹ¤»áÖ§³Ö½¨ÉèÌìÏÂÀÍÄ£¹¤½³Á¢ÒìÊÂÇéÊÒÃûµ¥¡·£¬ £¬£¬£¬£¬£¬£¬Ê¯Ò©¼¯ÍÅ¡°Àî´ºÀ×Á¢ÒìÊÂÇéÊÒ¡±ÈÙÁÐÆäÖУ¬ £¬£¬£¬£¬£¬£¬³ÉΪÌìϹæÄ£ÄÚ»ñµÃ´ËÏîÖ§³ÖµÄÖ÷ÒªÁ¢ÒìÔØÌå¡£¡£¡£¡£¡£ÌìÏÂ×ܹ¤»á½«¸øÓèÈëÑ¡µÄÁ¢ÒìÊÂÇéÊÒÒ»´ÎÐÔ½òÌù×ʽð10ÍòÔª£¬ £¬£¬£¬£¬£¬£¬Ö÷ÒªÓÃÓÚ½±ÀøÁ¢ÒìÊÂÇéÊÒ³ÉÔ±Á¢Òì´´Á¢¡£¡£¡£¡£¡£

¼ÓÔØ¸ü¶à
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿